"The price of greatness is responsibility." Sir Winston Churchill


Search the IBPA



Top Menu

Menu Sidebar

IBPA Issues
About IBPA
IBPA Constitution
FAQ-s
IBPA Events
Individual Membership
Institutional Membership
IBPA Forums / Groups
Cooperation with IBPA
Links

Publications
IBPA Careers Newsletter
Past Issues
Industry Publications
Promote Yourself within the Industry
Submit Your Article

Career Center: Employers
Job Posting
Free Resume Database
Volunteers Database

Career Center: Job Seekers
Now Hiring
Submit Resume
Career Training
Nurses Careers in Biopharm
Scholarship Programs
Internship Programs
Resume Editing & Interview Coaching
Volunteer for the Industry
Download IBPA Career Info Brochure

Industry Directories and Listings
Pharmaceutical Companies
Contract Research Organizations
Professional Associations
Recruiters and Staffing Agencies
Clinical Research Centers
Consulting Companies
Education & Training Institutions
Jobs and Resume Searching Directories
Research and Development Companies
Industry Service Providers
List Your Company

Investor's Center
Offers
Calls

Contact IBPA
USAChapter
Canadian Chapter
European Chapter
Asian Chapter

Start Your Career in Biotech with IBPA Scholarship Programs
Untitled Document



Subscribe to our "Careers in the Biopharmaceutical Industry" newsletter:

Name*:

Email*:

City:

Country:

Phone:

To unsubscribe, click here

 

 

Clinical surveillance

From Wikipedia, the free encyclopedia.

 

Contents

[hide]

[edit]

 

Introduction

Clinical surveillance refers to the act of surveilling a clinical syndrome that have a significant impact on public health. Such techniques have been used in particular for infectious diseases. Many large institutions, such as the WHO, or the Centers for Disease Control and Prevention, have created data bases, and modern computer systems that can tract and monitor emerging outbreaks of illnesses such as influenza, SARS, HIV, to biologic terrorism, such as the recent Anthrax attack on the post office system in the United States. Many states have cancer registries to monitor the incidence of cancers to determine the prevalence, and possible cause of these illnesses.

Other illnesses such as chronic diseases such as obesity, and diabetes, as well as social illness such as domestic violence, are increasingly being integrated into epidemiologic data bases that are being used in Cost Benefit Analysis in determining governmental funding for research and prevention. The benefits of such data cannot be underscored, but much of the statistics involves attaching worth to human lives, or years lived, with complex concepts as the converging of survival, quality of life, and productivity measures. The promotion of population based health care, that designed to reach an entire population, increasingly is integrated with converging registries, and outcomes increasingly being monitored as measurement of performance is a form of clinical surveillance.


 

[edit]

 

Pharmaceutical Surveillance and Marketing


Pharmaceutical companies, in an effort to maintain a competitive edge, have engaged in physician profiling for the purposes of marketing and advertisement to key physicians within a particular community. The effectiveness of monitoring, and cater marketing to individuals has a tremendous cost on society, in that surveillance of prescribing habits has lead to many physicians prescribing unnecessary medicines for the elderly, as well as the young. So hence, a clinical syndrome is monitored in terms of how a syndrome can be treated, such as that found in Alzheimer's disease. Also, with recent laws on electronic privacy, items purchased in retail drug stores that are not medicines, or are over the counter medicines, are items that manufactures can collect data on the purchasing consumers for marketing purposes, and is HIPAA compliant.

The emphasis of patient centered care, is in contrast to the above emphasis of population based health care and is a form of clinical sousveillance.

[edit]

 

Patient Autonomy


A very basic and intuitive way of understanding the importance between surveillance, and clinical sousveillance stems from patients keeping track and understanding which medicines they have been prescribed. It is often wise to check medication lists, and for patients to ask nurses what certain pills are prior to taking them: a note book, or log, will help the patient keep track of the intricate detail of ones treatment plan during a hospitalization. The nurses need to know what the patient is taking, and if any adverse drug effect has occurred, and the patient needs to know which medicines have been prescribed, to ensure correct treatment plan. When this evolves as a collaborative environment, medication errors are less likely to occur.

Another way of looking at the balance between Clinical Surveillance and Clinical Sousveillance is in regards to breast cancer screening: it is a well established fact that most breast masses are found by the patients themselves, and this is an important form self evaluation that works best if done regularly. This form of self evaluation is most efficacious if coupled with Mammography, and physician evaluation. So hence, the balance between self surveillance, and clinical surveillance, increases ones odds of early detection of breast cancer. So hence, the act of surveillance is a form of clinical monitoring that can range from self monitoring, to monitoring yearly mammograms. The patient's active participation is clinical sousveillance.


 

[edit]

 

Surveillance of Medical Errors

The fact that everyday, medical errors occur in all parts of the medical industry: how we are to deal with such errors raises a serious challenge for society and intersects with the field of disclosure. An institution that has in place systems of conflict resolution and transparency, will in the long run have less errors occur. The active participation of all members upon a medical team, including the patient and his/her advocates. This is quickly posing complex questions of who tells the patient when an error has occurred, and intersects with the complexity of privacy ( referred to HIPAA in the United States) laws that can favor the privacy of the institution versus the individual. Equiveillance represents a balance where all parties have at their disposal the tools of information gathering.

[edit]

 

Future and Advocacy


Increasingly, as information technology converges with bio-informatics, with the ability to map and categorize illness into the concept of real time, the issues of human freedom and privacy are brought to surface. Institutions such as the EFF, as well as advocates, such as Dan Gilmore, Steve Mann, and Stephanie Perrin have been collecting empirical data on the nature of authority in the context of surveillance via the development of multiple personal cyborglogs. An extreme form of patient monitoring is evolving with implantable RFID chipping, that has been traditionally used for monitoring migration patterns of animals, and more recently, for monitoring domestic cattle, has further raised concerned that unbalanced surveillance can create tremendous social problems with yet to be understood consequences. The evolution of social sorting has created a trend of clinical counter surveillance, or clinical sousveillance. The evolution of peer to peer personal area network that can collect information and be communicated machine to machine is a natural anthropologic response to humans interacting with machines and correlates with human computer interaction research. The ability for persons to be aware of how they are being surveillanced touches upon the theory of wearable computing and personal empowerment of human destiny.


As society begins to look at new methods of reducing medication and hospital errors, informatic systems are converging with RFID systems. An extreme method has been brought forward by the Verichip product,where a RFID chip is implanted into the subject's arm.

Hacking [1]implantable RFID chips has also been described as a form of clinical sousveillance. Maintaining a license free operation system that works with ones body has been suggested by many privacy activists, and the concern of maintaining self determination has been posed by writers such David Brin.


 

[edit]

 

References


 

  •  
    • University of Washington, Dept of Epidemiology, on-course on Epidemiology: Introduction to Epidemiologic Methods[[2]]
    • University of Washington, Dept of Epidemiology, on-course on Epidemiology: Cost & Outcomes Research[[3]]
    • Anoequity Blog: issues in privacy and computing[[4]]
    • JAMIA: Implementing Syndromic Surveillance: A Practical Guide Informed by the Early Experience [[5]]
    • JAMIA: Automated Syndromic Surveillance for the 2002 Winter Olympics [[6]]
    • Healthcare IT Collaboration in Massachusetts: The Experience of Creating Regional First published July 27, 2005 as JAMIA PrePrint; doi:10.1197/jamia.M1866[[7]]
    • RFID and Global Privacy Policy [[8]]
    • Lecture notes from Thomas E. Finucane, M.D. [[9]]
    • Up to date public comments by Thomas E. Finucane, M.D[[10]]
    • Medical Error Disclosure, Mediation Skills, and Malpractice Litigation: A Demonstration Project in Pennsylvania. Albert W. Wu, MD, MPH Special Article Review [[11]]
 



External links




Learn More About the Biopharmaceutical Industry and Clinical Research:


Category:

Logo sidebar
  • Analytical Chemistry
  • Bioinformatics
  • Biology
  • Biochemistry
  • Biotechnology
  • Biotechnology Companies
  • Cell Imaging
  • Chemistry
  • Chemists
  • Crystallography
  • Ecology
  • Environmentalism
  • Genetic Engineering
  • Genetically Modified Organisms
  • Genetics
  • Health
  • Health Care
  • Health Sciences
  • Medical Specialities
  • Medicine
  • Molecular Genetics
  • Pharmaceutical Industry
  • Pharmacy
  • Pharmacology

  • Powered by Wikipedia, the free encyclopedia. Articles were developed by IBPA volunteers.

    Logo sidebar

    A

    B

    C

    D

    E

    F

    G

    I

    K

    L

    M

    N

    P

    Q

    R

    S

    T


    Logo sidebar


    IBPA Sponsors and Active Supporters

    http://www.payoneer.com/
    Access Clinical Trials

    Access Clinical Trials
    Access Clinical Trials


    Allied Research International
    Allied Research International

    Altaspera Global Services Inc.
    Altaspera Global Services

    Financial Planning and Personal Insurance
    For Canadian Pharmaceutical Industry Executives


    Biorole Scientific Solutions
    Biorole Scientific Solutions

    CEREPROTEC INC. Development of Novel Neuroprotective Drugs
    CEREPROTEC INC. Development of Novel Neuroprotective Drugs

    Recruitment Advertising Agencies
    Recruitment Advertising Agencies

    Cellular Technology Ltd.
    Cellular Technology Ltd.

    Clinical Trial Network
    Free Database of Clinical Investigators

    ClinQua Clinical Trials Inc.
    ClinQua Clinical Trials Inc.

    Coronis Clinical Research Organization
    Coronis Clinical Research Organization

    CPIC Latin America
    CPIC Latin America

    Espoir Bridge Recruiters
    Espoir Bridge Recruiters

    Genentech
    Genentech

    ILS SA
    Independent Research and Laboratory Solutions

    Inova Health Research
    Inova Health Research, Inc.

    Kriger Research Group International
    Kriger Research Group International

    LCCT
    LCCT

    Metrics Research
    Complete Research Solutions on a Single Platform

    Pharmalef Developments
    Pharmalef Developments

    PrimeHealth Clinical Research Organization
    PrimeHealth Clinical Research Organization

    Research & Development RA SA
    Research & Development RA SA

    Scios Inc.
    Scios Inc. - Manufacturer of Health Care Products

    Scios Inc.
    Southeast Regional Research Group LLC.

    UniMR
    UniMR Clinical Research

    YM BioSciences
    YM BioSciences

    Become IBPA Sponsor
    Post Your Logo Here

    ©2004 International Biopharmaceutical Association Inc., all rights reserved
    Privacy Policy - Terms of Use

    Google